We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Clears Bot Image’s AI Software for Detection of Prostate Cancer
FDA Clears Bot Image’s AI Software for Detection of Prostate Cancer
Omaha, Neb.-based medical imaging software company Bot Image has received FDA clearance for its ProstatID tool, a cloud-based artificial intelligence (AI) software product that helps detect and diagnose prostate cancer.